Home » Topics » BioWorld Science

BioWorld Science
RSS

Tumor-targeted siRNA/pDNA dual delivery system reprograms the tumor microenvironment

Feb. 13, 2020

11 potential blockbuster drugs offer hope, threaten budgets

Feb. 13, 2020

ApoE, largest genetic risk factor for AD, also affects synucleinopathies

Feb. 13, 2020

New SNF2L2 inhibitors presented by Epizyme

Feb. 13, 2020

Hanmi Science describes new FLT3 and/or FLT3 ITD mutant inhibitors

Feb. 13, 2020

Japanese investigators synthesize new PTPN11 inhibitors

Feb. 13, 2020

Novartis identifies new NLRP3 inflammasome inhibitors

Feb. 13, 2020

Chinese researchers patent PI3K inhibitors

Feb. 13, 2020

G-721-0282, novel CHI3L1 ligand with anti-proliferative effects in models of osteosarcoma

Feb. 13, 2020

FASN as a new prognostic biomarker in Wilms' tumor

Feb. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...